XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2023
Dec. 31, 2022
Assets:    
Cash and cash equivalents $ 13,043 $ 12,945
Investments 3,145 2,778
Accounts receivable, net 32,927 27,276
Inventories 17,954 19,090
Assets held for sale 0 908
Other current assets 3,074 2,636
Total current assets 70,143 65,633
Long-term investments 21,667 21,096
Property and equipment, net 13,022 12,873
Operating lease right-of-use assets 17,564 17,872
Goodwill 91,261 78,150
Intangible assets, net 29,624 24,803
Separate accounts assets 3,200 3,228
Other assets 4,825 4,620
Total assets 251,306 228,275 Close
Liabilities:    
Accounts payable 14,874 14,838
Pharmacy claims and discounts payable 21,497 19,423
Health care costs payable 12,550 10,142
Policyholders’ funds 1,440 1,500
Accrued expenses 22,571 18,745
Other insurance liabilities 4,748 1,089
Current portion of operating lease liabilities 1,741 1,678
Current portion of long-term debt 2,132 1,778
Liabilities held for sale 0 228
Total current liabilities 81,553 69,421
Long-term operating lease liabilities 16,441 16,800
Long-term debt 59,782 50,476
Deferred income taxes 4,250 4,016
Separate accounts liabilities 3,200 3,228
Other long-term insurance liabilities 5,333 5,835
Other long-term liabilities 6,237 6,730
Total liabilities 176,796 156,506 Close
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,767 shares issued and 1,287 shares outstanding at September 30, 2023 and 1,758 shares issued and 1,300 shares outstanding at December 31, 2022 and capital surplus 48,829 48,193
Treasury stock, at cost: 480 shares at September 30, 2023 and 458 shares at December 31, 2022 (33,831) (31,858)
Retained earnings 60,343 56,398
Accumulated other comprehensive loss (1,004) (1,264)
Total CVS Health shareholders’ equity 74,337 71,469
Noncontrolling interests 173 300
Total shareholders’ equity 74,510 71,769 Close
Total liabilities and shareholders’ equity $ 251,306 $ 228,275